Patrick Wood
Stock Analyst at Morgan Stanley
(3.25)
# 1,098
Out of 5,106 analysts
118
Total ratings
53.33%
Success rate
2.05%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintains: Equal-Weight | $76 → $83 | $82.08 | +1.12% | 7 | Dec 8, 2025 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $123 → $135 | $126.79 | +6.48% | 3 | Dec 2, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Equal-Weight | $17 → $23 | $21.39 | +7.53% | 6 | Dec 2, 2025 | |
| RXST RxSight | Maintains: Equal-Weight | $9 → $10 | $12.62 | -20.76% | 3 | Dec 2, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $56 → $51 | $35.99 | +41.71% | 4 | Dec 2, 2025 | |
| DXCM DexCom | Upgrades: Overweight | $63 → $75 | $66.96 | +12.01% | 10 | Dec 2, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $197 → $210 | $200.89 | +4.53% | 6 | Dec 2, 2025 | |
| BAX Baxter International | Maintains: Underweight | $19 → $15 | $19.15 | -21.67% | 6 | Dec 2, 2025 | |
| BLCO Bausch + Lomb | Upgrades: Overweight | $14 → $21 | $16.99 | +23.60% | 9 | Dec 2, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Equal-Weight | $74 → $80 | $83.96 | -4.72% | 8 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $125 → $130 | $92.58 | +40.42% | 7 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $84 → $80 | $78.80 | +1.52% | 5 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $276 → $295 | $251.79 | +17.16% | 7 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $75 → $81 | $83.08 | -2.50% | 9 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $80 → $103 | $82.98 | +24.13% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $110 → $72 | $108.88 | -33.87% | 4 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $191 → $173 | $126.88 | +36.35% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $234 → $317 | $295.70 | +7.20% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $10 | $2.56 | +290.63% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $50 → $37 | $24.13 | +53.34% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $121.35 | - | 5 | Dec 11, 2017 |
The Cooper Companies
Dec 8, 2025
Maintains: Equal-Weight
Price Target: $76 → $83
Current: $82.08
Upside: +1.12%
TransMedics Group
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $123 → $135
Current: $126.79
Upside: +6.48%
Tandem Diabetes Care
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $17 → $23
Current: $21.39
Upside: +7.53%
RxSight
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $9 → $10
Current: $12.62
Upside: -20.76%
PROCEPT BioRobotics
Dec 2, 2025
Maintains: Overweight
Price Target: $56 → $51
Current: $35.99
Upside: +41.71%
DexCom
Dec 2, 2025
Upgrades: Overweight
Price Target: $63 → $75
Current: $66.96
Upside: +12.01%
Becton, Dickinson and Company
Dec 2, 2025
Maintains: Overweight
Price Target: $197 → $210
Current: $200.89
Upside: +4.53%
Baxter International
Dec 2, 2025
Maintains: Underweight
Price Target: $19 → $15
Current: $19.15
Upside: -21.67%
Bausch + Lomb
Dec 2, 2025
Upgrades: Overweight
Price Target: $14 → $21
Current: $16.99
Upside: +23.60%
GE HealthCare Technologies
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $74 → $80
Current: $83.96
Upside: -4.72%
Oct 23, 2025
Maintains: Overweight
Price Target: $125 → $130
Current: $92.58
Upside: +40.42%
Aug 21, 2025
Maintains: Equal-Weight
Price Target: $84 → $80
Current: $78.80
Upside: +1.52%
Aug 8, 2025
Maintains: Overweight
Price Target: $276 → $295
Current: $251.79
Upside: +17.16%
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $75 → $81
Current: $83.08
Upside: -2.50%
Jul 15, 2025
Upgrades: Overweight
Price Target: $80 → $103
Current: $82.98
Upside: +24.13%
May 6, 2025
Maintains: Underweight
Price Target: $110 → $72
Current: $108.88
Upside: -33.87%
May 5, 2025
Maintains: Overweight
Price Target: $191 → $173
Current: $126.88
Upside: +36.35%
Nov 11, 2024
Maintains: Overweight
Price Target: $234 → $317
Current: $295.70
Upside: +7.20%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $18 → $10
Current: $2.56
Upside: +290.63%
Jul 15, 2024
Downgrades: Underweight
Price Target: $50 → $37
Current: $24.13
Upside: +53.34%
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $121.35
Upside: -